Processing

Please wait...

Settings

Settings

Goto Application

1. MYPI 96005367 - ISOXAZOLINE ISOTHIAZOLINE AND PYRAZOLINE FACTOR XA INHIBITORS

EP0874629ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
Appl.Date 17.12.1996
Appl.No 96944844 Applicant BRISTOL MYERS SQUIBB PHARMA CO Pub.Kind A1,B1,A4 Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 04.11.1998
CA2240946ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR XA INHIBITORS
Appl.Date 17.12.1996
Appl.No 2240946 Applicant THE DUPONT MERCK PHARMACEUTICAL COMPANY Pub.Kind C Pub.Lang en
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 03.07.1997
AU1997013358Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors
Appl.Date 17.12.1996
Appl.No 13358/97 Applicant Du Pont Merck Pharmaceutical Company, The Pub.Kind A
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 11.09.1997
WO/1997/023212ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
Appl.Date 17.12.1996
Appl.No PCT/US1996/020076 Applicant THE DU PONT MERCK PHARMACEUTICAL COMPANY Pub.Kind A Pub.Lang en
Inclusion Criteria IC1
PCT application from which the family originated.
Pub.Date 03.07.1997
ES2219706ISOXAZOLINAS, ISOTIAZOLINAS Y PIRAZOLINAS INHIBIDORES DEL FACTOR XA.
Appl.Date 17.12.1996
Appl.No E96944844 Applicant DUPONT PHARMACEUTICALS COMPANY Pub.Kind T3 Pub.Lang es
Inclusion Criteria IC6
Connected by priority field.
Pub.Date 01.12.2004
DE000069632548ISOXAZOLIN, ISOTHIAZOLIN UND PYRAZOLIN ALS FAKTOR Xa INHIBITOREN
Appl.Date 17.12.1996
Appl.No 69632548 Applicant BRISTOL MYERS SQUIBB PHARMA CO Pub.Kind T,T2
Inclusion Criteria IC6
Connected by priority field.
Pub.Date 02.06.2005
JP2001502655Xa因子阻害薬であるイソオキサゾリン、イソチアゾリンおよびピラゾリン
Appl.Date 17.12.1996
Appl.No 1997523762 Pub.Kind A Pub.Lang ja
Inclusion Criteria IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Date 27.02.2001
ZA1996/10704ISOXAZOLINE ISOTHIAZOLINE AND PYRAZOLINE FACTOR XA INHIBITORS
Appl.Date 19.12.1996
Appl.No 1996/10704 Applicant DUPONT MERCK PHARMACEUTICAL CO Pub.Kind B Pub.Lang en
Inclusion Criteria IC6
Connected by priority field.
Pub.Date 26.08.1998
MYPI 96005367ISOXAZOLINE ISOTHIAZOLINE AND PYRAZOLINE FACTOR XA INHIBITORS
Appl.Date 19.12.1996
Appl.No PI 96005367 Applicant E.I. DU PONT DE NEMOURS AND COMPANY Pub.Kind A
Inclusion Criteria IC6
Connected by priority field.
Pub.Date 21.06.1997